OSR Health (OSRHW) Exchange Rate Effect (2024 - 2026)
OSR Health (OSRHW) posted Exchange Rate Effect of -$85393.4 for Q1 2026, down 89.31% sequentially from -$45108.0 in Q4 2025, and down 409.85% YoY from $27559.2 in Q1 2025.
OSR Health (OSRHW) Exchange Rate Effect (2024 - 2026) Analysis & Trends
OSR Health has reported Exchange Rate Effect for 3 years, with the latest figure at -$85393.4 in Q1 2026.
- Quarterly Exchange Rate Effect fell 409.85% year-over-year to -$85393.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$107059.8 (down 238.01% YoY) and the FY2025 annual result came in at -$38415.0, down 3.45% from the prior year.
- Exchange Rate Effect retreated to -$85393.4 in Q1 2026 per OSRHW's latest filing, from -$45108.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $129455.0 in Q3 2024 and troughed at -$134128.0 in Q4 2024.
- A 3-year average of -$17882.6 and a median of -$22210.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect jumped 1155.98% in 2025, then sank 409.85% in 2026.
- Over 3 years, Exchange Rate Effect stood at -$134128.0 in 2024, then jumped by 66.37% to -$45108.0 in 2025, then slumped by 89.31% to -$85393.4 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$85393.4, -$45108.0, and -$84818.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | -287,000.00 |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | -31,245.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85,393.40 |
| Mar 31, 2026 | -85,393.40 |
| Dec 31, 2025 | -45,108.00 |
| Dec 31, 2025 | -45,108.00 |
| Sep 30, 2025 | -84,818.00 |
| Sep 30, 2025 | -84,818.00 |
| Jun 30, 2025 | 108,259.58 |
| Jun 30, 2025 | 108,259.58 |
| Mar 31, 2025 | -16,748.58 |
| Mar 31, 2025 | -16,748.58 |
| Dec 31, 2024 | -134,128.00 |
| Dec 31, 2024 | -134,128.00 |
| Sep 30, 2024 | 129,455.00 |
| Sep 30, 2024 | 129,455.00 |
| Jun 30, 2024 | -10,252.00 |
| Jun 30, 2024 | -10,252.00 |
| Mar 31, 2024 | -22,210.00 |
| Mar 31, 2024 | -22,210.00 |